Literature DB >> 7592130

Response of Saccharomyces cerevisiae strains to antineoplastic agents.

A Delitheos1, I Karavokyros, E Tiligada.   

Abstract

The effect of several antineoplastic agents on Saccharomyces cerevisiae strains has been investigated. Minimum inhibitory concentration (MIC), minimum cytotoxic concentration (MCC) and median effective concentration (EC50) were determined to identify strains with inherent sensitivity to the agents tested. Several strains proved to be sensitive to the antimetabolites 5-fluorouracil and methotrexate as well as to doxorubicin and cis-platine. On the contrary m-amsacrine, procarbazine, vinca alcaloids, melphalan and hydroxyurea were inactive at concentrations up to 400 micrograms ml-1. The strain ATCC 2366, the most relatively sensitive to the agents tested, was used for studying the effect of treatment duration and of drug concentration on cell survival. Methotrexate and cis-platine, which according to MIC and MCC tests seemed ineffective for this strain, reduced survival significantly after 6 h of treatment. A correlation of the shape of the survival curves with MIC and MCC values was attempted.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592130     DOI: 10.1111/j.1365-2672.1995.tb03151.x

Source DB:  PubMed          Journal:  J Appl Bacteriol        ISSN: 0021-8847


  3 in total

1.  Anticancer drugs as inducers of thermotolerance in yeast.

Authors:  V Miligkos; E Tiligada; K Papamichael; E Ypsilantis; A Delitheos
Journal:  Folia Microbiol (Praha)       Date:  2000       Impact factor: 2.099

2.  Induction of morphological alterations by antineoplastic agents in yeast.

Authors:  E Stavrinidis; A Delitheos; E Tiligada
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

3.  Effect of the Hsp90 modulators on the heat-shock response in eukaryotic cells.

Authors:  K Papamichael; I Vovou; V Miligkos; E Stavrinidis; A Delitheos; E Tiligada
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.